Published in J Neurotrauma on November 21, 2013
Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injury. J Control Release (2015) 0.85
The role of IL-17 promotes spinal cord neuroinflammation via activation of the transcription factor STAT3 after spinal cord injury in the rat. Mediators Inflamm (2014) 0.83
Neuroprotective effect of rapamycin on spinal cord injury via activation of the Wnt/β-catenin signaling pathway. Neural Regen Res (2015) 0.82
Neuroprotective Effect of Simvastatin via Inducing the Autophagy on Spinal Cord Injury in the Rat Model. Biomed Res Int (2015) 0.81
Simvastatin inhibits neural cell apoptosis and promotes locomotor recovery via activation of Wnt/β-catenin signaling pathway after spinal cord injury. J Neurochem (2016) 0.81
Omega-conotoxin MVIIC attenuates neuronal apoptosis in vitro and improves significant recovery after spinal cord injury in vivo in rats. Int J Clin Exp Pathol (2014) 0.80
Recent advances in the pharmacologic treatment of spinal cord injury. Metab Brain Dis (2014) 0.79
Time representation of mitochondrial morphology and function after acute spinal cord injury. Neural Regen Res (2016) 0.77
Downregulating hypoxia-inducible factor-1α expression with perfluorooctyl-bromide nanoparticles reduces early brain injury following experimental subarachnoid hemorrhage in rats. Am J Transl Res (2016) 0.76
Protective effects of perfluorooctyl-bromide nanoparticles on early brain injuries following subarachnoid hemorrhage in rats. Am J Transl Res (2015) 0.76
Methylprednisolone promotes recovery of neurological function after spinal cord injury: association with Wnt/β-catenin signaling pathway activation. Neural Regen Res (2016) 0.75
Netrin-1 Improves Functional Recovery through Autophagy Regulation by Activating the AMPK/mTOR Signaling Pathway in Rats with Spinal Cord Injury. Sci Rep (2017) 0.75
Oxygen Sensing with Perfluorocarbon-Loaded Ultraporous Mesostructured Silica Nanoparticles. ACS Nano (2017) 0.75
Bio-inspired nanomedicine strategies for artificial blood components. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2017) 0.75
Activation of the Nrf2/ARE signaling pathway by probucol contributes to inhibiting inflammation and neuronal apoptosis after spinal cord injury. Oncotarget (2017) 0.75
A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma (1995) 13.48
Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med (1985) 11.68
Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol (1996) 5.46
Programmed cell death and the control of cell survival: lessons from the nervous system. Science (1993) 4.63
Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg (1991) 3.85
Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med (1997) 3.55
The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science (1989) 3.14
Degeneration and regeneration of axons in the lesioned spinal cord. Physiol Rev (1996) 2.98
A monitored contusion model of spinal cord injury in the rat. J Neurotrauma (1992) 2.93
The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma (2004) 2.48
Vascular mechanisms in the pathophysiology of human spinal cord injury. J Neurosurg (1997) 2.24
The pathology of human spinal cord injury: defining the problems. J Neurotrauma (2004) 2.17
Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J (2004) 1.93
Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv Neurol (1993) 1.90
Review of current evidence for apoptosis after spinal cord injury. J Neurotrauma (2000) 1.83
The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp Neurol (1995) 1.78
Review of treatment trials in human spinal cord injury: issues, difficulties, and recommendations. Neurosurgery (2006) 1.78
Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery (1999) 1.70
A quantitative spatial analysis of the blood-spinal cord barrier. I. Permeability changes after experimental spinal contusion injury. Exp Neurol (1996) 1.58
Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience (2001) 1.55
Recent advances in pathophysiology and treatment of spinal cord injury. Adv Physiol Educ (2002) 1.52
Perfluorocarbon emulsion in the cardiopulmonary bypass prime reduces neurologic injury. Ann Thorac Surg (1997) 1.43
Pathology of experimental spinal cord trauma. I. The necrotic lesion as a function of vascular injury. Lab Invest (1978) 1.41
Behavioral testing after spinal cord injury: congruities, complexities, and controversies. J Neurotrauma (2004) 1.30
Update on the treatment of spinal cord injury. Prog Brain Res (2007) 1.29
Complete compensation in skilled reaching success with associated impairments in limb synergies, after dorsal column lesion in the rat. J Neurosci (1999) 1.16
Neuropathology of experimental spinal cord ischemia in the rabbit. J Neuropathol Exp Neurol (1982) 1.13
The influence of severity of spinal cord ischemia in the etiology of delayed-onset paraplegia. Ann Surg (1991) 1.10
Current status of clinical trials for acute spinal cord injury. Injury (2005) 1.09
The relationships among the severity of spinal cord injury, motor and somatosensory evoked potentials and spinal cord blood flow. Electroencephalogr Clin Neurophysiol (1989) 1.07
Regional spinal cord blood flow in rats after severe cord trauma. J Neurosurg (1978) 1.05
Ultrastructural evidence for arteriolar vasospasm after spinal cord trauma. Neurosurgery (1996) 1.03
Perfluorocarbon emulsions as a promising technology: a review of tissue and vascular gas dynamics. J Appl Physiol (1985) (2009) 0.99
Effects of hyperbaric oxygenation and tissue oxygen studies in experimental paraplegia. J Neurosurg (1972) 0.99
Induction and its spread of apoptosis in rat spinal cord after mechanical trauma. Neurosci Lett (1996) 0.94
FTY720 reduces inflammation and promotes functional recovery after spinal cord injury. J Neurotrauma (2009) 0.93
Quantitative analysis of acute axonal pathology in experimental spinal cord contusion. J Neurotrauma (1997) 0.91
Early administration of a second-generation perfluorochemical decreases ischemic brain damage in a model of permanent middle cerebral artery occlusion in the rat. Neurol Res (2005) 0.86
Spinal cord energy metabolism following compression trauma to the feline spinal cord. J Neurosurg (1980) 0.85
Influence of posttraumatic hypoxia on behavioral recovery and histopathological outcome following moderate spinal cord injury in rats. J Neurotrauma (2001) 0.85
Perfluorocarbon emulsions improve cognitive recovery after lateral fluid percussion brain injury in rats. Neurosurgery (2008) 0.84
Perfluorocarbon emulsion improves cerebral oxygenation and mitochondrial function after fluid percussion brain injury in rats. Neurosurgery (2004) 0.83
Spinal cord contusion causes acute plasma membrane damage. J Neurotrauma (2009) 0.82
Effect of acute spinal cord compression injury on regional spinal cord blood flow in primates. J Neurosurg (1976) 0.81
Relationship between posttraumatic ischemia and hemorrhage in the injured rat spinal cord as shown by colloidal carbon angiography. Neurosurgery (1986) 0.81
Perflubron emulsion prevents PMN activation and improves myocardial functional recovery after cold ischemia and reperfusion. J Surg Res (2006) 0.80
Altered blood flow and secondary injury in experimental spinal cord trauma. J Neurosurg (1978) 0.79
Microcirculatory disturbances during the early phase following experimental spinal cord trauma in the rat. Adv Neurol (1978) 0.79
Effect of perfluorocarbons on brain oxygenation and ischemic damage in an acute subdural hematoma model in rats. J Neurosurg (2005) 0.79
Randomized safety studies of intravenous perflubron emulsion. I. Effects on coagulation function in healthy volunteers. Anesth Analg (2000) 0.78
The therapeutic window for methylprednisolone treatment of acute spinal cord injury: implications for cell injury mechanisms. Res Publ Assoc Res Nerv Ment Dis (1993) 0.78
Perfluorocarbons: recent developments and implications for neurosurgery. J Neurosurg (1996) 0.77
Reduction of hypoxia by perfluorocarbon emulsion in a traumatic spinal cord injury model. J Neurosurg Spine (2008) 0.77
Intrathecal oxygen concentration as a new indicator of spinal cord ischemia. Acta Med Okayama (1997) 0.76
Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med (2011) 2.18
Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza. J Infect Dis (2012) 1.49
Surgical management of traumatic brain injury: a comparative-effectiveness study of 2 centers. J Neurosurg (2013) 1.44
A phase I study of a tropism-modified conditionally replicative adenovirus for recurrent malignant gynecologic diseases. Clin Cancer Res (2010) 1.21
Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma. Clin Cancer Res (2009) 1.13
One-pot cyclization of 2-aminophenethyl alcohols: a novel and direct approach to the synthesis of N-acyl indolines. J Org Chem (2007) 1.00
Prognostic value of mucin 4 expression in colorectal adenocarcinomas. Cancer (2010) 1.00
A trial of Scrambler therapy in the treatment of cancer pain syndromes and chronic chemotherapy-induced peripheral neuropathy. J Pain Palliat Care Pharmacother (2013) 0.98
AHD2.0: an update version of Arabidopsis Hormone Database for plant systematic studies. Nucleic Acids Res (2010) 0.95
Secular trends in body composition for children and young adults: the Fels Longitudinal Study. Am J Hum Biol (2012) 0.94
Testing for differences in distribution tails to test for differences in 'maximum' lifespan. BMC Med Res Methodol (2008) 0.94
Two pole air gap electrospinning: Fabrication of highly aligned, three-dimensional scaffolds for nerve reconstruction. Acta Biomater (2010) 0.93
FTY720 reduces inflammation and promotes functional recovery after spinal cord injury. J Neurotrauma (2009) 0.93
Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells. Breast Cancer Res Treat (2013) 0.92
Titanium miniplates or stainless steel wire for cranial fixation: a prospective randomized comparison. J Neurosurg (2002) 0.89
Elective irradiation of pelvic lymph nodes during postprostatectomy salvage radiotherapy. Cancer (2012) 0.87
Identifying appropriate patients for early salvage radiotherapy after prostatectomy. J Urol (2013) 0.81
Two-dimensional molecular space with regular molecular structure. Langmuir (2007) 0.79
CPU-GPU hybrid accelerating the Zuker algorithm for RNA secondary structure prediction applications. BMC Genomics (2012) 0.79
Intraoperative injection of radiocolloid for sentinel node biopsy in breast cancer. J Nucl Med Technol (2013) 0.78
Enhancement of neighbouring-group participation in Cu0-promoted cross-coupling gem-difluoromethylenation of aryl/alkenyl halides with 1,3-azolic difluoromethyl bromides. Chemistry (2014) 0.78
Sustained survival and maturation of adult neural stem/progenitor cells after transplantation into the injured brain. J Neurotrauma (2011) 0.78
Effectiveness of a standardized education process for tracheostomy care. Laryngoscope (2014) 0.78
Room-temperature Cu(II)-catalyzed aromatic C-H azidation for the synthesis of ortho-azido anilines with excellent regioselectivity. Chem Commun (Camb) (2014) 0.77
Reduction of hypoxia by perfluorocarbon emulsion in a traumatic spinal cord injury model. J Neurosurg Spine (2008) 0.77
An efficient regioselective hydrodifluoromethylation of unactivated alkenes with TMSCF₂CO₂Et at ambient temperature. Chem Commun (Camb) (2014) 0.76
Ethyl 2-phenyl-5-trifluoro-methyl-1,3-thia-zole-4-carboxyl-ate. Acta Crystallogr Sect E Struct Rep Online (2008) 0.75
Chlorido[1,1'-(5-methyl-1,3-phenyl-ene)bis-(3,5-dimethyl-1H-imidazol-2-yl-idene)]platinum(II). Acta Crystallogr Sect E Struct Rep Online (2013) 0.75
Nucleophile-dependent regioselective reaction of (S)-4-benzyl-2-fluoroalkyl-1,3-oxazolines. J Org Chem (2013) 0.75
Methyl chloroacetate as an extraction solvent for coupling liquid-liquid semimicroextraction with micellar electrokinetic chromatography through on-capillary decomposition for the separation of neutral compounds with concentration enhancement. J Chromatogr A (2007) 0.75
Research on beam characteristics in a large-Fresnel-number unstable-waveguide hybrid resonator with parabolic mirrors. Appl Opt (2016) 0.75
[Cerebral edema and changes of cerebral blood volume in patients with head injuries]. Orv Hetil (2002) 0.75
Expression of matrix metalloproteinases-12 in ST-segment elevation myocardial infarction: A case-control study. Medicine (Baltimore) (2017) 0.75
Extracorporeal membrane oxygenation support as a life-saving measure for acute respiratory distress syndrome after craniectomy. J Neurosurg Anesthesiol (2014) 0.75
Capabilities of transition metals in retarding the bonding of carbon atoms to minimize dendritic graphene. Nanoscale (2017) 0.75
Highly effective copper-mediated gem-difluoromethylenation of arylboronic acids. Chem Commun (Camb) (2014) 0.75
Reactive two-dimensional layered material with regular chlorine groups. J Colloid Interface Sci (2007) 0.75
C-9 fluorenyl substituted anthracenes: a promising new family of blue luminescent materials. Org Lett (2010) 0.75
A visualization method for probing grain boundaries of single layer graphene via molecular beam epitaxy. Nanotechnology (2017) 0.75
Attainment of surgical competence in otolaryngology training. Laryngoscope (2014) 0.75
Equivocal or ambiguous terminologies in pathology: focus of continuous quality improvement? Am J Surg Pathol (2013) 0.75